Skip to content

Testosterone-induced Muscle Memory and Underlying Mechanisms

Long-term Effects of Anabolic Androgenic Steroids on Muscle Growth Potential: Testosterone-induced Muscle Memory and Underlying Mechanisms

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06188767
Enrollment
30
Registered
2024-01-03
Start date
2025-04-01
Completion date
2028-12-01
Last updated
2025-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal Muscle Physiology

Brief summary

The purpose of this project is to investigate underlying mechanisms of testosterone- and resistance training-induced muscle hypertrophy and muscle memory in humans.

Interventions

DRUGTestosterone Undecanoate

Following testosterone/placebo injection, participants undergo supervised resistance training for 4 weeks. This period is followed by a washout period with no drug and either continued resistance training or detraining for 16 weeks. Thereafter, another 4-week period with supervised resistance training is commenced, with no drug.

Sponsors

Morten Hostrup, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * BMI of \<26 and normal ECG and blood pressure

Exclusion criteria

* Smoking * Chronic disease, * Use of prescription medication * Pain due to current or previous musculoskeletal injury * Resistance training more than once per week in the 12 months leading up to the intervention * Current or previous use of prohibited anabolic substances

Design outcomes

Primary

MeasureTime frameDescription
Fiber cross-sectional areaThe change in fiber cross-sectional is assessed at baseline, 4, 20 and 24 weeksImmunohistochemistry to determine fiber cross-sectional area
MyonucleiThe change in myonuclei is assessed at baseline, 4, 20 and 24 weeksImmunohistochemistry to determine number of myonuclei
Skeletal muscle proteomeThe change in the muscle proteome is assessed at baseline, 4, 20 and 24 weeksPathway enrichment analysis of the muscle proteome using mass spectrometry-based proteomics

Secondary

MeasureTime frameDescription
Lean massThe change in lean mass is assessed at baseline, 4, 20 and 24 weeksLean mass assessed by dual X-ray absorptiometry (DXA)
Satellite cellsThe change in satellite cells is assessed at baseline, 4, 20 and 24 weeksImmunohistochemistry to determine number of satellite cells
Muscle strengthThe change in 1-repetition maximum is assessed at baseline, 4, 20 and 24 weeks1-repetition maximum

Countries

Denmark

Contacts

Primary ContactLukas Moesgaard
lm@nexs.ku.dk+4561724440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026